Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | |||
Founding Date | Founding Date 2013 | Founding Date 2003 | Founding Date 2014 |
Type | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations København, DK HQ | Locations Bundoora, AU HQ München, DE Hummelstown, US | Locations Oxford, GB HQ Dublin, IE Burlington, US |
Employees | Employees 7 | Employees 20 | Employees 1061% decrease |

vivoPharm is a company that provides preclinical oncology and immuno-oncology services.
View company
Blue Earth Diagnostics is a molecular imaging diagnostics company.
View company